Related Experiment Video

Updated: Jul 20, 2026

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness

Published on: May 3, 2018

Pulse pressure and mortality from cerebrovascular diseases in type 2 diabetic patients: the Verona Diabetes Study

Giacomo Zoppini1, Giuseppe Verlato, Cristina Zamboni

  • 1Division of Endocrinology and Metabolic Diseases, University of Verona, Verona, Italy.

Cerebrovascular Diseases (Basel, Switzerland)
|September 14, 2006
PubMed

Insights

Mean pulse pressure strongly predicts cardiovascular mortality, especially from cerebrovascular diseases, in type 2 diabetes patients. This finding highlights pulse pressure as a key risk indicator for diabetic patients.

Area of Science:

  • Cardiology
  • Diabetology
  • Epidemiology

Background:

  • Pulse pressure (PP) is a known predictor of cardiovascular disease mortality in general and diabetic populations.
  • Investigating specific cardiovascular mortality in type 2 diabetes is crucial for targeted interventions.

Purpose of the Study:

  • To examine the association between pulse pressure and mortality from cerebrovascular and ischemic heart diseases.
  • To determine the predictive value of mean pulse pressure and its coefficient of variation in type 2 diabetic patients.

Main Methods:

  • A cohort of 1,128 type 2 diabetic patients (aged 56-74) was followed for 10 years.
  • Blood pressure measurements were analyzed for mean and coefficient of variation of pulse pressure.
  • Specific causes of death, including cerebrovascular and ischemic heart disease, were assessed.

Main Results:

  • Mean pulse pressure independently predicted all-cause and cardiovascular mortality.
  • Mean pulse pressure, not its coefficient of variation, strongly predicted cerebrovascular disease mortality.
  • A 10 mm Hg increase in mean pulse pressure was associated with an 86% rise in cerebrovascular mortality risk.

Conclusions:

  • Mean pulse pressure is a significant predictor of cardiovascular mortality in type 2 diabetes.
  • The predictive power of mean pulse pressure is particularly notable for cerebrovascular events.
  • Pulse pressure emerges as a critical risk factor for cerebrovascular mortality in this diabetic cohort.
Abstract

Related Concept Videos

Blood Pressure01:24

Blood Pressure

The movement of blood in a human body, commonly referred to as blood flow, is determined by the volume of blood that traverses a certain section of the bodily system per unit time. It is the rhythmic contraction of the heart's ventricles that primarily instigates this movement. As the ventricles contract, blood is forced into the prominent arteries, which then flow from areas of greater pressure to lower pressure areas. This movement continues into smaller arteries and arterioles and...
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...